Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations

Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous system tumour in adults. It has extremely poor prognosis since the current standard of care, comprising of gross total resection and temozolomide (TMZ) chemoradiotherapy, prolongs survival, but does not provide a...

Descripción completa

Detalles Bibliográficos
Autores principales: Niedbała, Marcin, Malarz, Katarzyna, Sharma, Gitanjali, Kramer-Marek, Gabriela, Kaspera, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060812/
https://www.ncbi.nlm.nih.gov/pubmed/35509452
http://dx.doi.org/10.2147/OTT.S215997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060812/
https://www.ncbi.nlm.nih.gov/pubmed/35509452
http://dx.doi.org/10.2147/OTT.S215997

Ejemplares similares